Literature DB >> 8290186

High-dose oxytocin: 20- versus 40-minute dosage interval.

A J Satin1, K J Leveno, M L Sherman, D McIntire.   

Abstract

OBJECTIVE: To determine whether an increase in the oxytocin dosing interval would decrease the incidence of uterine hyperstimulation.
METHODS: This study included 1801 consecutive pregnancies receiving high-dose oxytocin. Oxytocin was used for labor augmentation in 1167 and induction in 634 women. Twenty- and 40-minute dosage intervals were compared. The study period was based on an 80% likelihood of detecting 5 and 10% differences in the cesarean and hyperstimulation rates, respectively. Statistics were analyzed with chi 2, Fisher, and Wilcoxon rank-sum tests where appropriate. Multivariate logistic regression and analysis of covariance were used to control for confounding demographic variables.
RESULTS: Comparison of the 20- and 40-minute regimens for labor induction yielded no differences in the rates of cesarean delivery for dystocia (16 versus 19%) or fetal distress (5 versus 6%). The 20-minute regimen for augmentation was associated with a significant reduction in cesarean for dystocia (8 versus 12%; P = .05). The incidence of uterine hyperstimulation was greater with the 20-minute than the 40-minute regimen for induction (40 versus 31%; P = .02), but not for augmentation (31 versus 28%). Neonatal outcomes were unaffected by the dosage interval for both augmentation and induction.
CONCLUSION: A 40-minute dosing interval for high-dose oxytocin offers no clear advantage over a 20-minute interval. Both regimens were safe and efficient, with no differences in perinatal outcome. The 20-minute interval was associated with fewer cesareans for dystocia when used for labor augmentation, whereas the 40-minute interval resulted in less hyperstimulation when used for labor induction.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8290186

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  6 in total

Review 1.  Chemotherapeutic induction of labour. A rational approach.

Authors:  E M Xenakis; J M Piper
Journal:  Drugs       Date:  1997-07       Impact factor: 9.546

2.  Labor induction and augmentation with oxytocin: pharmacokinetic considerations.

Authors:  M Gonser
Journal:  Arch Gynecol Obstet       Date:  1995       Impact factor: 2.344

Review 3.  Intravenous oxytocin alone for cervical ripening and induction of labour.

Authors:  Zarko Alfirevic; Anthony J Kelly; Therese Dowswell
Journal:  Cochrane Database Syst Rev       Date:  2009-10-07

4.  High dose and low dose oxytocin regimens as determinants of successful labor induction: a multicenter comparative study.

Authors:  Melese Gezahegn Tesemma; Demisew Amenu Sori; Desta Hiko Gemeda
Journal:  BMC Pregnancy Childbirth       Date:  2020-04-21       Impact factor: 3.007

5.  Perinatal outcomes of high dose versus low dose oxytocin regimen used for labor induction and factors associated with adverse perinatal outcome in four hospitals of Ethiopia: a multicenter comparative study.

Authors:  Melese Gezahegn Tesemma; Demisew Amenu Sori; Desta Hiko Gemeda
Journal:  BMC Pregnancy Childbirth       Date:  2021-08-28       Impact factor: 3.007

Review 6.  High-dose versus low-dose oxytocin infusion regimens for induction of labour at term.

Authors:  Aaron Budden; Lily J Y Chen; Amanda Henry
Journal:  Cochrane Database Syst Rev       Date:  2014-10-09
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.